Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease
Open accessPublished version of a preprint
The DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Abstract
Background: Growth differentiation factor-15 (GDF-15) is a marker of inflammation, oxidative stress and it is associated with adverse prognosis in cardiovascular disease. The aim of the present cohort study is to investigate the prognostic value of GDF-15 in patients with coronary artery disease (CAD) during long-term follow up. Methods: A total of 3641 consecutive patients with CAD were prospectively enrolled into the study and followed up for major adverse cardiovascular events (MACEs) and all-cause death up to 5.3–7.6 years. Plasma GDF-15 was measured and clinical data and long-term events were registered. The patients were subsequently divided into three groups by the levels of GDF-15 and the prognostic value of GDF-15 level with MACEs and all-cause death was evaluated. Results: After a median follow-up at 6.4 years later, 775 patients (event rate of 21%) had developed MACEs and 275 patients died (event rate of 7.55%). Kaplan–Meier analysis indicated that the patients with GDF-15 > 1800 ng/L were significantly associated with an increased risk of MACEs and all-cause death. Cox regression analysis indicated that GDF-15 > 1800 ng/L were independently associated with the composite of MACEs (HR 1.74; 95% CI 1.44–2.02; P < 0.001) and all-cause death (HR 2.04; 95% CI 1.57–2.61; P < 0.001). For MACEs, GDF-15 significantly improved the C-statistic (area under the curve, 0.583 [95% CI 0.559–0.606] to 0.628 [0.605–0.651]; P < 0.001), net reclassification index (0.578; P = 0.031), and integrated discrimination index (0.021; P = 0.027). For all-cause death, GDF-15 significantly improved the C-statistic (0.728 [95% CI 0.694–0.761] to 0.817 [0.781–0.846]; P < 0.001), net reclassification index (0.629; P = 0.001), and integrated discrimination index (0.035; P = 0.002). Conclusions: In the setting of CAD, GDF-15 is associated with long-term MACEs and all-cause death, and provides incremental prognostic value beyond traditional risks factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a stress-responsive cytokine, GDF15 is elevated in many cardiac disorders and may reflect underlying valvular pathological processes driven by chronic inflammation and oxidative stress 26-28 .”
From Connecting proteomics and genomics to identify causal biomarkers specific for aortic valve stenosis (2025) · cites this paper as [27]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proceedings of the National Academy of Sciences of the United States of America
Dowling, J. E., & Wald, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06752.x · Cited by 17,893
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
Kyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32335-3 · Cited by 4,081
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
HOSKINS, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
Journal of The American College of Cardiology
(2015) · Wilderness & Environmental Medicine · doi:10.1016/j.wem.2015.03.023 · Cited by 2,584
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P., Larson, M. G., Tofler, G. H., Levy, D., Newton-Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,343
The Global Burden of Cardiovascular Diseases and Risk Factors
Mensah, G. A., Roth, G. A., & Fuster, V. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.10.009 · Cited by 1,324
Cited by
Sjøberg, K. A., Sigvardsen, C. M., Alvarado-Diaz, A., Andersen, N. R., Larance, M., Seeley, R. J., Schjerling, P., Knudsen, J. G., Katzilieris‐Petras, G., Clemmensen, C., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.016 · Cited by 102
Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome
Katsioupa, M., Kourampi, I., Oikonomou, E. K., Tsigkou, V., Theofilis, P., Charalambous, G., Marinos, G., Gialamas, I., Zisimos, K., Anastasiou, A., et al. (2023) · Life · doi:10.3390/life13101992 · Cited by 87
Omar, M., Jensen, J., Kistorp, C., Højlund, K., Videbæk, L. M., Tuxen, C., Larsen, J. H., Andersen, C. F., Gustafsson, F., Køber, L., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01463-2 · Cited by 70
Sun, X., Duan, J., Gong, C., Feng, Y., Hu, J., Gu, R., & Xu, B. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.025266 · Cited by 70
From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction
Stătescu, C., Anghel, L., Tudurachi, B.-S., Tudurachi, A., Benchea, L.-C., & Sascău, R. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169168 · Cited by 59
Metadata
- Authors
- Li, M., Duan, L., Cai, Y.-L., Li, H.-Y., Hao, B.-C., Chen, J.-Q., & Liu, H.-B.
- Affiliations
- Chinese PLA General Hospital (CN)
- Venue
- Cardiovascular Diabetology
- Published
- 2020-08-03
- Volume
- 19
- Issue
- 1
- Pages
- 120-120
- ISSN
- 1475-2840 (ISSN-L)
- PMC
- PMC7398317
- OpenAlex
- W3047598126
- Cited by
- 71
- References
- 67
- Citations by year
- 2026: 15 · 2025: 18 · 2024: 16 · 2023: 12 · 2022: 5 · 2021: 4 · 2020: 1
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cardiovascular Diabetology (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Key Projects of Logistics Scientific Research Project of Chinese PLA (17BJZ48)
- National Key Research Program of China (2017YFC0840103)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- growth differentiation factor 15, coronary artery disease, major adverse cardiovascular events, all-cause mortality, prognostic factors, inflammation, oxidative stress, risk stratification, risk reclassification, plasma biomarkers, long-term follow-up, cardiovascular risk prediction
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cause of Death, Coronary Artery Disease, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Risk Factors, Time Factors, Biomarkers, Risk Assessment, Growth Differentiation Factor 15
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease. https://app.cochat.ai/papers/10.1186/s12933-020-01092-7
- The paper
- Li, M., Duan, L., Cai, Y.-L., Li, H.-Y., Hao, B.-C., Chen, J.-Q., & Liu, H.-B. (2020). Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-020-01092-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.